Company intelligence / Profile preview

NanoTherm Therapeutics

Ownership: Private
Development stage: Commercial

Overview

NanoTherm Therapeutics has developed the CE-marked NanoTherm Therapy System for precise treatment of solid tumors. The system uses bioengineered iron oxide nanoparticles injected into tumor tissue; these are then heated by an external alternating magnetic field to ablate cancer cells or sensitize them to conventional therapies. Over 900 patients have been treated with NTTS in Europe for recurrent glioblastoma. Clinical trials are ongoing or planned for primary glioblastoma and other solid tumor indications such as lung and liver cancers. Preclinical collaborations include work on pancreatic cancer with Mayo Clinic[1][5].

Therapeutic areas: Oncology
Modalities: NanoparticleDevice
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

NanoTherm

Commercial

Indications: Recurrent glioblastoma

Partnerships

Mayo Clinic (preclinical research on GI cancers)[5]MagForce NT GmbH as manufacturing partner[1]

Beyond the preview

Go deeper on NanoTherm Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoTherm Therapeutics.

Explore the full profile